Synthesis and characterization of bradykinin B2 receptor agonists containing constrained dipeptide mimics

Journal of Medicinal Chemistry

Volumn 42, Issue 20, 1999, Pages 4193-4201

  Amblard, Muriel ^a   Daffix, Isabelle ^a   Bergé, Gilbert ^a   Calmès, Monique ^a   Dodey, Pierre ^b   Pruneau, Didier ^b   Paquet, Jean Luc ^b   Luccarini, Jean Michel ^b   Bélichard, Pierre ^b   Martinez, Jean ^a  

^a CNRS   (France)

^b Laboratoires Fournier SA   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BRADYKININ B2 RECEPTOR; BRADYKININ B2 RECEPTOR AGONIST; ICATIBANT; JMV 1116; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; RECEPTOR AFFINITY; SYNTHESIS; UMBILICAL VEIN; VASOCONSTRICTION;

ANIMALS; BRADYKININ; CELL LINE; CLONING, MOLECULAR; DIPEPTIDES; FEMALE; HUMANS; LIGANDS; MOLECULAR MIMICRY; MUSCLE CONTRACTION; MUSCLE, SMOOTH, VASCULAR; RADIOLIGAND ASSAY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, BRADYKININ B2; RECEPTORS, BRADYKININ; STRUCTURE-ACTIVITY RELATIONSHIP; UMBILICAL CORD; UTERINE CONTRACTION;

EID: 0033533755     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm9901531     Document Type: Article

References (28)

1. For reviews see: (a) Olson, G. L.; Bolin, D. R.; Bonner, M. P.; Bös, M.; Cook, C. M.; Fry D. C.; Graves, B. J.; Hatada, M.; Hill, D. E.; Kahn, M.; Madison, V. S.; Rusiecki, V. K.; Sarabu, R.; Sepinwall, J.; Vincent, G. P.; Voss, M. E. Concepts and progress in the development of peptide mimetics. J. Med. Chem. 1993, 36, 3039-3049.
2. (b) Fairlie, D. P.; Abbenante, G.; March, D. R. Macrocyclic peptidomimetics - Forcing peptides into bioactive conformations. Curr. Med. Chem. 1995, 2, 654-686.
3. Rich, D. H. Peptidase inhibitors. In Comprehensive medicinal chemistry: The rational design, mechanistic study and therapeutic application of chemical compounds; Hansch, C., Sammes, P. G., Taylor, J. B., Eds.; Pergamon Press: New York, 1990; pp 391-44 and references therein.
4. Amblard, M.; Daffix, I.; Bedos, Ph.; Bergé, G.; Pruneau, D.; Paquet, J. L.; Luccarini, J. M.; Bélichard, P.; Dodey, P.; Martinez, J. Design and synthesis of potent bradykinin agonists containing a benzothiazepine moiety. J. Med. Chem. 1999, 42, 4185-4192.
5. Lembeck, F.; Griesbacher, T.; Eckhardt, M.; Henke, St.; Breipohl, G.; Knolle, J. New, long-acting, potent bradykinin antagonists. Br. J. Pharmacol. 1991, 102, 297-304.
6. Dorer, F. E.; Ryan, J. W.; Steward, J. M. Hydrolysis of bradykinin and it's higher homologues by angiotensine-converting enzyme. Biochem. J. 1974, 14, 915-917.
7. Freidinger, R. M.; Perlow, D. S.; Veber, D. F. Protected lactam-bridged dipeptides for use as conformational constraints in peptides. J. Org. Chem. 1982, 47, 104-109.
8. Thorsett, E. D.; Harris, E. E.; Aster, S. D.; Peterson, E. R.; Snyder, J. P.; Springer, J. P.; Hirshfield, J.; Tristam, E. W.; Patchett, A. A.; Ulm, E. H.; Vassil, T. C. Conformationally restricted inhibitors of angiotensin converting enzyme: synthesis and computations. J. Med. Chem. 1986, 29, 251-260.
9. Hoyer, D.; Awad, M. M. A.; Salvino, J. M.; Seoane, P. R.; Dolle, R. E.; Houck, W. T.; Sawutz, D. G. ACE inhibitors as a template of bradykinin B2 receptor antagonists. Bioorg. Med. Chem. Lett. 1995, 5, 367-370.
10. Kyle, D. J.; Martin, J. A.; Farmer, S. G.; Burch, R. M. Design and conformational analysis of several highly potent bradykinin receptor antagonists. J. Med. Chem. 1991, 34, 1230-1233.
11. Kyle, D. J.; Martin, J. A.; Burch, R. M.; Carter, J. P.; Lu, S.; Meeker, S.; Prosser, J. C.; Sullivan, J. P.; Togo, J.; Noronha-Blob, L.; Sinsko, J. A.; Walters, R. F.; Whaley, L. W.; Hiner, R. N. Probing the bradykinin receptor: mapping the geometric topography using ethers of hydroxyproline in novel peptides. J. Med. Chem. 1991, 34, 2649-2653.
12. Kyle, D. J.; Blake, P. R.; Smithwick, D.; Green, L. M.; Martin, J. A.; Sinsko, J. A.; Summers, M. F. NMR and computational evidence that high-affinity bradykinin receptor antagonists adopt C-terminal β-tums. J. Med. Chem. 1993, 36, 1450-1460.
13. Evans, B. E.; Rittle, M. G.; Bock, M. G.; DiPardo, R. M.; Freidinger, R. M.; Whitter, W. L.; Lundell, G. F.; Veber, D. F.; Anderson, P. S.; Chang, R. S. L.; Lotti, V. J.; Cerino, D. J.; Chen, T. B.; Kling, P. J.; Kuntel, K. A.; Springer, J. P.; Hirshfield, J. Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonists. J. Med. Chem. 1988, 31, 2235-2246.
14. Pothion, C.; Fehrentz, J. A.; Aumelas, A.; Loffet, A.; Martinez, J. Synthesis of pyrrolidine-2,4-diones from urethane N-carboxyanhydrides (UNCAs). Tetrahedron Lett. 1996, 37, 1027-1030.
15. Slade, J.; Stanton, J. L.; Ben-David, D.; Mazzenga, G. C. Angiotensin converting enzyme inhibitors: 1,5-benzothiazepine derivatives. J. Med. Chem. 1985, 28, 1517-1521.
16. Nagel, A. A. Benzothiazepine and benzoxazepine derivatives as cholecystokinin receptor antagonists. International Patent Application WO 94/01421, Jan 20, 1994.
17. De Lombaert, S.; Blanchard, L.; Stamford, L. B.; Sperbeck, D. M.; Grim, M. D.; Jenson, T. M.; Rodriguez, H. R. Practical syntheses of a novel tricyclic dipeptide mimetic based on a [6H]-azepino indole nucleus: Application to angiotensin-converting enzyme inhibition. Tetrahedron Lett. 1994, 35, 7513-7516.
18. Freidinger, R. M.; Perlow, D. S.; Veber, D. F. Protected lactam-bridged dipeptides for use as conformational constraints in peptides. J, Org. Chem. 1982, 47, 104-109.
19. Brady, S. F.; Paleveda, W. J.; Arison, B. H.; Freidinger, R. M.; Nutt, R. F.; Veber, D. F. An improved procedure for peptide cyclization. In Peptides: Structure and Function; Proceedings of the Eighth American Peptide Symposium; Hruby, V. J., Rich, D. H., Eds.; Pierce Chemical Co.: Rockford, IL, 1983; pp 127-130.
20. Barany, G.; Merrifield, R. B. Solid-phase peptide synthesis. In The Peptides, Analysis, Synthesis and Biology; Gross, E., Meienhofer, J., Eds.; Academic Press: New York, 1979; Vol. 2, pp 3-284.
21. Castro, B.; Dormoy, J. R.; Evin, G.; Selve, C. Peptide coupling reagents. N-[oxytris(dimethylamino)phosphoniumbenzotriazole hexafluorophosphate. Tetrahedron Lett. 1975, 1219-1222.
22. Inamura, T.; Nomura, R.; Black, K. L. Intracarotid infusion of RMP-7, a method for selective drug delivery to brain tumors. J. Neurosurg. 1994, 81, 752-758.
23. Gisin, B. F. The preparation of Merrifield-resins through total esterification with cesium salts. Helv. Chim. Acta 1973, 56, 1476-1482.
24. Kaiser, E.; Colescott, R. L.; Bossinger, C. D.; Cook, P. I. Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides. Anal. Biochem. 1970, 34, 595-598.
25. 3CN); gradient 0-100% B in 50 min.
26. Paquet, J.-L.; Luccarini, J.-M.; Fouchet, C.; Defrêne, E.; Loillier, B.; Robert, C.; Bélichard, P.; Cremers, B.; Pruneau, D. Pharmacological characterization of the bradykinin 62 receptor: interspecies variability and dissociation between binding and functional responses. Br. J. Pharmacol. 1999, 126, 1083-1090.
27. Bastian, S.; Loillier, B.; Paquet, J. L.; Pruneau, D. Stable expression of human kinin B1 receptor in 293 cells: pharmacological and functional characterization. Br. J. Pharmacol. 1997, 122, 393-399.
28. Bradford, M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 721, 248-254.